“Many studies have documented racial, socioeconomic, geographic, and other disparities for US patients with multiple myeloma pertaining to diagnosis and frontline management,” researchers wrote in Blood Cancer Journal. “In...
Read More
In an analysis of 1,034 fit adults aged 70 years and younger, age and genetic features were identified as the factors most associated with AML outcomes.
Read More
The mutation burden in DLBCL varies significantly based on patient sex and age, according to recent findings published in HemaSphere.
Read More
Study results implicate oral dysbiosis in chronic graft-vs-host disease (GVHD) and show that targeting the oral microbiome may improve GVHD outcomes.
Read More
Identifying the JAK2V617F mutation has improved understanding of what causes overproduction of red blood cells, platelets, and neutrophils in polycythemia vera.
Read More
